295 Capecitabine plus irinotecan (CAPIRI) vs capecitabine plus oxaliplatin (CAPOX) as first-line therapy of advanced colorectal cancer (ACRC): updated results of a randomized phase II trial
Open Access
- 30 September 2003
- journal article
- abstracts
- Published by Elsevier in European Journal of Cancer Supplements
- Vol. 1 (5), S90-S91
- https://doi.org/10.1016/s1359-6349(03)90328-4